Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Key Facts on Billing Drug Wastage

From the College  |  January 24, 2023

Rituximab is available in single-use vials of 100 mg/10 mL and 500 mg/50 mL. The CPT/HCPCS code and description for rituximab is J9312, rituximab 10mg. If 750 mg of rituximab is administered, it is appropriate to bill for 75 units J9312 because the CPT/HCPCS code J9312 defines the unit for rituximab as 10mg. If 800 mg total are utilized, but only 750 mg are administered, then 50 mg are wasted and documented in the medical record. Because the administered amount requires billing 75 units of J9312, 50 mg of wastage is billed on a separate service line as five units of J9312, along with the JW modifier, that is not utilized.

Example #2

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

J1745 is the CPT/HCPCS code for infliximab 10 mg, but the drug is sold as 100 mg of lyophilized infliximab in a 20 ml vial. If the patient received 360 mg of infliximab, the correct way to bill this is J1745 x 36 (36 x 10 = 360 mg); four units were wasted, so 40 mg would have to be documented as drug wastage and coded with the JW modifier to indicate drug wastage.

Additional Reminders

Providers are responsible for submission of accurate documentation of services performed and are expected to submit claims for services rendered using valid CPT/HCPCS code combinations. Documentation is expected to be maintained in the patient’s medical record and be made available to payers upon request. The medical record should include the name of the drug, dosage, route of administration and time and date given. When a portion of the drug is discarded, the medical record must clearly document the amount administered and the amount wasted.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Keep in mind, although the JW modifier was created by the CMS, its use is not limited to CMS members or plans. Practices will need to verify with payers their policy and guidelines for drug wastage because every reimbursement type is determined by the patient’s plan and covered services.

For questions on drug wastage or additional information on coding and documentation guidelines, contact the ACR practice management department at [email protected]. For additional information on drug wastage guidelines, refer to CMS Medicare Claims Processing Manual, Chapter 17, Drugs and Biologicals.

Table: Billing Drug Wastage Do’s & Don’ts

Do’s Don’ts
Refer to your CMS contractor to verify appropriate billing of discarded drugs. Do not use the JW modifier when the billing unit is equal to or greater than the total actual dose and the amount discarded. For example, if one billing unit is equal to 10 mg and 7 mg of a drug was administered to a patient and 3 mg of the drug was discarded, the JW modifier cannot be used to report the discarded drug because the sum of the administered dose (7 mg) and the discarded dose (3 mg) is equal to the billing unit of 10 mg.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Billing/Coding Tagged with:Billing & Coding

Related Articles

    New HCPCS Modifiers Replace -59 on January 1, 2015

    December 1, 2014

    Referred to as -X modifiers, they are designed to define specific subsets of -59 modifier

    Rheumatology Coding Corner Answer: Billing Infusion Procedure with JW Modifier

    April 20, 2017

    Take the challenge. CPT: 99214-25, 96413, 96375, 96361-59, J1745 x 4 J1745 JW* x 36, J1200 x1 ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEICD-10: M45.09, T50.995A, R06.02, E66.3, Z68.2 Rationale Modifier 25 is appropriate to use because it indicates the patient received a significant, separately identifiable E/M service on the same day as the infliximab infusion. This…

    Coding Corner Answer: March

    March 1, 2015

    Coding for chemotherapy infusion with a drug reaction

    Coding Corner Answer: A Quiz on Modifiers

    February 18, 2019

    Take the challenge. 1. A—Modifier -25 is defined as a significant, separately identifiable evaluation and management (E/M) service by the same physician or other qualified healthcare professional on the same day of the procedure or other service. It is to be placed on the E/M visit only because it attests to the payer there is…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences